Show simple item record

dc.contributor.authorLyratzopoulos, G
dc.contributor.authorAbel, GA
dc.contributor.authorBrown, CH
dc.contributor.authorRous, BA
dc.contributor.authorVernon, SA
dc.contributor.authorRoland, M
dc.contributor.authorGreenberg, DC
dc.date.accessioned2019-02-07T13:23:21Z
dc.date.issued2012-11-12
dc.description.abstractBackground: Understanding socio-demographic inequalities in stage at diagnosis can inform priorities for cancer control. Patients and methods: We analysed data on the stage at diagnosis of East of England patients diagnosed with any of 10 common cancers, 2006-2010. Stage information was available on 88 657 of 98 942 tumours (89.6%). Results: Substantial socio-demographic inequalities in advanced stage at diagnosis (i.e. stage III/IV) existed for seven cancers, but their magnitude and direction varied greatly by cancer: advanced stage at diagnosis was more likely for older patients with melanoma but less likely for older patients with lung cancer [odds ratios for 75-79 versus 65-69 1.60 (1.38-1.86) and 0.83 (0.77-0.89), respectively]. Deprived patients were more likely to be diagnosed in advanced stage for melanoma, prostate, endometrial and (female) breast cancer: odds ratios (most versus least deprived quintile) from 2.24 (1.66-3.03) for melanoma to 1.31 (1.15-1.49) for breast cancer. In England, elimination of sociodemographic inequalities in stage at diagnosis could decrease the number of patients with cancer diagnosed in advanced stage by 5600 annually. Conclusions: There are substantial socio-demographic inequalities in stage at diagnosis for most cancers. Earlier detection interventions and policies can be targeted on patients at higher risk of advanced stage diagnosis. ©The Author 2012.en_GB
dc.description.sponsorshipNational Institute for Health Research (NIHR)en_GB
dc.identifier.citationVol. 24 (3), pp. 843 - 850en_GB
dc.identifier.doi10.1093/annonc/mds526
dc.identifier.grantnumberPost-doctoral Fellowshipen_GB
dc.identifier.urihttp://hdl.handle.net/10871/35800
dc.language.isoenen_GB
dc.publisherOxford University Pressen_GB
dc.rights© The Author 2012. Published by Oxford University Press on behalf of the European Society for Medical Oncology. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.en_GB
dc.subjectcanceren_GB
dc.subjectdemographicen_GB
dc.subjectdiagnosisen_GB
dc.subjectinequalitiesen_GB
dc.subjectsocio-economicen_GB
dc.subjectstageen_GB
dc.titleSocio-demographic inequalities in stage of cancer diagnosis: Evidence from patients with female breast,lung, colon, rectal, prostate, renal, bladder, melanoma, ovarian and endometrial canceren_GB
dc.typeArticleen_GB
dc.date.available2019-02-07T13:23:21Z
dc.identifier.issn0923-7534
dc.descriptionThis is the final published version. Available from Oxford University Press via the DOI in this record.en_GB
dc.identifier.journalAnnals of Oncologyen_GB
dc.rights.urihttp://creativecommons.org/licenses/by-nc/3.0en_GB
pubs.euro-pubmed-idMED:23149571
dcterms.dateAccepted2012-09-07
rioxxterms.versionVoRen_GB
rioxxterms.licenseref.startdate2012-09-07
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2019-02-07T13:20:49Z
refterms.versionFCDVoR
refterms.dateFOA2019-02-07T13:23:25Z
refterms.panelAen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record

© The Author 2012. Published by Oxford University Press on behalf of the European Society for Medical Oncology.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Except where otherwise noted, this item's licence is described as © The Author 2012. Published by Oxford University Press on behalf of the European Society for Medical Oncology. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.